Skip to main content
. 2018 Nov 19;2(22):3118–3125. doi: 10.1182/bloodadvances.2018023432

Figure 1.

Figure 1.

AML relapse with NPM1mutoccurs earlier than relapse with NPM1wt. (A) RFS of patients with NPM1mut relapse and NPM1wt relapse. (B) OS following relapse of patients with NPM1mut relapse and NPM1wt relapse. 95% CI, 95% confidence interval; OS, overall survival; RFS, relapse-free survival.